Premier Research Names Patrick Melvin as Senior Director, Clinical Trial Management

Premier Research Names Patrick Melvin as Senior Director, Clinical Trial
Management

PHILADELPHIA, Jan. 15 /PRNewswire/ -- Premier Research Group plc
(AIM: PRG), the international pharmaceutical services group, announces the
appointment of Patrick Melvin as Senior Director, Clinical Trial Management
specializing in oncology-related research. In this position, Mr. Melvin will
play a leading role in the operations, strategic planning and corporate
development of Premier Research's growing portfolio of oncology business.
Over the past nine years, Mr. Melvin managed hematology/oncology programs
ranging from Phase I first-in-man studies through pivotal global Phase III
programs. His early phase experience included multiple variations of early
phase designs, including PK/PD studies, traditional dose-escalating maximum
tolerated dose studies, Simon two-stage studies, and adaptive design studies.
The later phase studies included extensive global experience in
hematology/oncology clinical research including clinical program and client
activities in the United States, Western and Eastern Europe, Latin America,
and Asia. His responsibilities incorporated consulting with clients on
clinical development plans and protocol design for new hematology/oncology
studies. Mr. Melvin began his clinical research career as a CRA at a global
clinical research organization and, after five years of serving in various
monitoring positions, entered project management specializing in hematology
and oncology drug development.
"Mr. Melvin is an exceptional addition to our team," said Krista
Armstrong, Ph.D., Vice President, Clinical Trial Management. "As we continue
to expand our presence within the oncology market, Mr. Melvin's substantial
clinical and management expertise will be beneficial in continuing to
establish Premier Research as an industry leader."
About Premier Research
Premier Research is a leading solutions-driven CRO leveraging their
commitment to therapeutic focus and scientific expertise to deliver clinical
trial services of the highest quality for biopharmaceutical and medical device
companies. They are leaders in clinical research for Analgesia, CNS,
Infectious Disease, and Oncology and have a wealth of experience in medical
device and pediatric research. Premier Research has 29 offices and operates in
more than 30 countries across Europe and North America. They employ a strong
international network of monitors and project management professionals
combined with regulatory, data management, statistical, scientific and medical
experts, and staff at a well-established network of dedicated clinical sites.
SOURCE Premier Research Group plc

Jessica Barag of Premier Research Group plc, +1-215-282-5391,
jessica.barag@premier-research.com